Release of Exotoxin A, Peptidoglycan and Endotoxin after Exposure of Clinical Pseudomonas aeruginosa Isolates to Carbapenems in vitro

Publisher： Karger

E-ISSN： 1421-9794|51|6|324-331

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.6, 2005-11, pp. : 324-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Activity of Ceftazidime, Cefepime and Imipenem on 1,005 Pseudomonas aeruginosa Clinical Isolates either Susceptible or Resistant to Beta-Lactams

By  

Chemotherapy, Vol. 46, Iss. 4, 2000-06 ,pp. : 229-234

Karger

Access to resources Recommend Favorite

Unchanged Antibiotic Susceptibility in Escherichia coli and Pseudomonas aeruginosa after Long-Term in vitro Exposure to Antineoplastic Drugs

By  

Chemotherapy, Vol. 58, Iss. 2, 2012-04 ,pp. : 118-122

Karger

Access to resources Recommend Favorite

Characterization of Fluoroquinolone and Carbapenem Susceptibilities in Clinical Isolates of Levofloxacin-Resistant Pseudomonas aeruginosa

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Susceptibility of 2,252 Pseudomonas aeruginosa Clinical Isolates Over 4 Years to 9 Antimicrobials in a Tertiary Greek Hospital

By  

Chemotherapy, Vol. 60, Iss. 5-6, 2015-0 ,pp. : 334-341

Karger

Access to resources Recommend Favorite

First Detection of OXA-10 Extended-Spectrum Beta-Lactamases and the Occurrence of mexR and nfxB in Clinical Isolates of Pseudomonas aeruginosa from Nigeria

By  

Chemotherapy, Vol. 61, Iss. 2, 2015-0 ,pp. : 87-92

Karger

Access to resources Recommend Favorite